Evaxion Biotech A/S (EVAX) has a market capitalization of $26.15M and trades at $4.14. The 52-week range is 1.2-12.15.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.4, Earnings Per Share (EPS) of $-1.21, annual revenue of $7.55M.
The stock has a beta of 0.20, operates in the Healthcare sector.
